GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their attributes such as body weight loss, protection of islet cells, promotion of islet cell proliferation, and minimal side effects
Because no matter how effective your treatment is during the months you are on it, what happens after you stop determines whether those results were temporary or transformative
note that the higher mass may call for a larger reconstitution volume to reach the same working concentration
Ashley Koff, RD 00:27:28 Often
Sources : Nutan.net , FDA guidelines on transdermal products, cosmetic regulatory databases
Aminian A, Zajichek A, Tu C, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE